bluebird bio Inc (NAS:BLUE)
$ 0.4171 0.0121 (2.99%) Market Cap: 81.10 Mil Enterprise Value: 376.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

bluebird bio Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript

May 19, 2021 / 05:55PM GMT
Release Date Price: $19.05 (-4.04%)
Luca Issi
RBC Capital Markets, Research Division - Research Analyst

Great, hello, everybody, and thank you for dialing in. My name is Luca Issi. I'm a senior biotech analyst here at RBC Capital Markets. And today, it's our great privilege to have Nick Leschly, CEO of bluebird bio; and Philip Gregory, CSO of bluebird bio, for a fireside chat. Nick, Greg, thanks so much for joining us. How are you guys doing today?

Nick Leschly
bluebird bio, Inc. - President, CEO & Director

Doing great. Thanks for having us, Luca.

Philip D. Gregory
bluebird bio, Inc. - Chief Scientific Officer

Very good. Glad speaking to you.

Luca Issi
RBC Capital Markets, Research Division - Research Analyst

Absolutely, my pleasure. And thanks again.

Questions & Answers

Luca Issi
RBC Capital Markets, Research Division - Research Analyst

So maybe, Nick, let's start with a big picture question here. Obviously, you announced the corporate split

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot